Company profile: Immunicon
1.1 - Company Overview
Company description
- Provider of proprietary cell-based research and diagnostic products focused on cancer, offering a PET/CT Center using PET/CT and CT imaging for precision diagnosis of cancer and dementia, biomarker research on HER2, PD-L1, FGFR2b, CLDN18.2, and MSI, and resources on treating HER2-positive cancers, including breast and biliary tract cancers. Their offerings help physicians understand, diagnose, treat, and monitor cancer.
Products and services
- Biomarker Research: Delivers research-grade resources on biomarkers HER2, PD-L1, FGFR2b, CLDN18.2, and MSI to give physicians better information to understand, diagnose, treat, and monitor cancer
- PET/CT Center: Offers a clinical-grade facility specializing in precision diagnosis of cancer and dementia using PET/CT and CT imaging technologies
- Cancer Treatment Information: Supplies oncology-focused resources and guides for the treatment of HER2-positive cancers, including breast and biliary tract cancers.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Immunicon
Ion Torrent
HQ: United States
Website
- Description: Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ion Torrent company profile →
Epitomics
HQ: United States
Website
- Description: Provider of monoclonal antibody technology and life science research tools, developing proprietary RabMAb® (Rabbit Monoclonal Antibody) antibodies with superior binding affinity, specificity, and bioactivity for research and diagnostic applications. Offerings include primary and secondary antibodies, recombinant options, antibody panels, proteins, and kits and reagents including ELISA kits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epitomics company profile →
Cold Chain Technologies
HQ: United States
Website
- Description: Provider of thermal packaging solutions protecting temperature-sensitive products for pharmaceutical, life sciences, and food services, including insulated parcel and pallet shippers, thermal cargo blankets, single-use systems (CCT Advanced SU48), reusable program management, smart digital solutions, logistics management, thermal packaging design, thermal modeling, temperature profile analysis, and an online solution selector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cold Chain Technologies company profile →
Magtivio
HQ: The Netherlands
Website
- Description: Provider of magnetic micro- and nano particles and complete kits for DNA extraction, circulating cfDNA analysis, NGS library preparation, and dye-terminator removal in Sanger sequencing, as well as magnetic separators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magtivio company profile →
PacBio
HQ: United States
Website
- Description: Provider of sequencing systems and technologies for genomic, epigenomic, and transcriptomic analysis, including Revio long-read sequencing, Onso short-read with Sequencing by Binding (SBB) for high accuracy, rare variant detection and difficult-region analysis, Sequel IIe for HiFi reads in whole-genome and RNA sequencing, HiFi sequencing, and Kinnex kits for high-throughput RNA workflows (full-length, single-cell, 16S rRNA).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PacBio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Immunicon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Immunicon
2.2 - Growth funds investing in similar companies to Immunicon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Immunicon
4.2 - Public trading comparable groups for Immunicon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →